Edit
DelMar Pharmaceuticals
http://www.delmarpharma.com/Last activity: 01.09.2020
Active - Reference to Kintara Therapeutics, Inc. NASDAQ: KTRA
Employees: 1-10
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Discovery ... | discoveryp... |
Mentions in press and media 4
| Date | Title | Description |
| 01.09.2020 | KINTARA THERAPEUTICS, INC. Kintara Therapeutics : Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million | SAN DIEGO, Sept. 1, 2020 /PRNewswire/ -- Kintara Therapeutics, Inc. ("Kintara" or the "Company") (Nasdaq: KTRA) announced today the final closing of its previously announced private placement of Series C Convertible Pref... |
| 01.09.2020 | Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million | |
| 21.07.2017 | Can the immunotherapy movement march into glioblastomas? | Brain cancers are always a challenge to treat, noted Jeffrey Bacha, cofounder and CEO of DelMar Pharmaceuticals, which has an investigational GBM drug in Phase 3 trials. “Unfortunately, there have been no real drug approvals in the field of... |
| - | Can the immunotherapy movement march into glioblastomas? | Sen. John McCain leaves a meeting of GOP senators in the U.S. Capitol June 22, 2017. On Wednesday, Mayo Clinic released a statement revealing that longstanding Republican Senator John McCain has an aggressive form of brain cancer. Called gl... |